Jasper Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.93

+0.02 (+1.97%)

As of May 16, 2:22 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 10 71%

Hold 4 29%

Sell 0 0%

Price Target

Analyst Price Target +4,273.3% upside

Low Target $28.40

Average Target $40.51

High Target $50.89

Current Price $0.93

Current
$0.93

Target
$40.51

$28.40 $40.51 avg $50.89

Scenario Analysis

Bear Case

$28.40

2,966.0%

Low target

Base Case

$40.51

+4,273.3%

Avg target

Bull Case

$50.89

+5,393.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.19

-87.1% from high

52-Week Low

$0.62

+48.7% from low

Target vs 52W High

$40.51

+463.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%